Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunological mechanisms underlying progression of chronic wounds in recessive dystrophic epidermolysis bullosa
Leonie F. A. Huitema, Taylor Phillips, Vitali Alexeev, et al.
Experimental Dermatology (2021) Vol. 30, Iss. 12, pp. 1724-1733
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

A prenatal skin atlas reveals immune regulation of human skin morphogenesis
Nusayhah Hudaa Gopee, Elena Winheim, Bayanne Olabi, et al.
Nature (2024) Vol. 635, Iss. 8039, pp. 679-689
Open Access | Times Cited: 18
Systems immunology integrates the complex endotypes of recessive dystrophic epidermolysis bullosa
Nell Hirt, Enzo Manchon, Qian Chen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Type VII Collagen Deficiency in the Oncogenesis of Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa
Andrew P. South, Martin Laimer, Mouhamed Gueye, et al.
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 11, pp. 2108-2119
Open Access | Times Cited: 14
Pro‐inflammatory immunity supports fibrosis advancement in epidermolysis bullosa: intervention with Ang‐(1‐7)
Rocco Bernasconi, Kerstin Thriene, Elena Romero‐Fernández, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 10
Open Access | Times Cited: 30
Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex
Н. А. Евтушенко, Arkadii K. Beilin, Anastasiya V. Kosykh, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12446-12446
Open Access | Times Cited: 30
ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa
Kathrin Dieter, Elke Niebergall‐Roth, Cristina Daniele, et al.
Cytotherapy (2023) Vol. 25, Iss. 7, pp. 782-788
Open Access | Times Cited: 12
Cascade-Targeted Nanoplatforms for Synergetic Antibiotic/ROS/NO/Immunotherapy against Intracellular Bacterial Infection
Xiaomei Dai, Xiaojun Liu, Xingxing Wang, et al.
Biomacromolecules (2024) Vol. 25, Iss. 5, pp. 3190-3199
Closed Access | Times Cited: 4
The Differentiation and Regeneration Potential of ABCB5+ Mesenchymal Stem Cells: A Review and Clinical Perspectives
Zheng He, Vytaute Starkuviene, Michael Keese
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 660-660
Open Access
Cytomegalovirus Colitis in 2 Patients With Kindler Syndrome
Abdulhamid Al-Hinai, Laila S Al Yazidi, Adawiya Al Jamei, et al.
The Pediatric Infectious Disease Journal (2025)
Closed Access
Epidermolysis bullosa for primary care providers: A practical review
Kennedy Sparling, Judith O’Haver, Muayad M. Shahin, et al.
Journal of General and Family Medicine (2025)
Open Access
Off-label use of recombinant adjuvanted Herpes Zoster vaccine in a 10-year-old high-risk patient affected by epidermolysis bullosa: A case report
Claudia Palmieri, Chiara Noviello, Lorenza Moscara, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients
Ignacia Fuentes, María Joao Yubero, Pilar Morandé, et al.
International Wound Journal (2022) Vol. 20, Iss. 3, pp. 774-783
Open Access | Times Cited: 11
New insight of itch mediators and proinflammatory cytokines in epidermolysis bullosa
Hong Ha Nguyen, Satoru Shinkuma, Ryota Hayashi, et al.
Journal of Cutaneous Immunology and Allergy (2022) Vol. 5, Iss. 3, pp. 78-87
Open Access | Times Cited: 9
Unveiling the value of C‐reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross‐sectional study
L. Quintana‐Castanedo, Silvia Sánchez‐Ramón, R. Maseda, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 8
Open Access | Times Cited: 1
Natural Occurrence of Autoantibodies against Basement Membrane Proteins in Epidermolysis Bullosa
Antoni Gostyński, Gilles F.H. Diercks, M.J. Escámez, et al.
Journal of Investigative Dermatology (2021) Vol. 142, Iss. 7, pp. 2014-2019.e3
Open Access | Times Cited: 9
Case report: bullous pemphigoid development underlies dystrophic epidermolysis bullosa disease worsening
Giovanni Di Zenzo, Giovanna Floriddia, Sabrina Rossi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
The prebiotic effects of amadumbe (Colocasia Esculenta) and okra (Abelmoschus esculentus) mucilage
Sharmista Gajadhar
(2023)
Open Access | Times Cited: 1
A human prenatal skin cell atlas reveals immune cell regulation of skin morphogenesis
Nusayhah Hudaa Gopee, Ni Huang, Bayanne Olabi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Skin Microbial Composition and Genetic Mutation Analysis in Precision Medicine for Epidermolysis Bullosa
Inna Syafarina, Maulida Mazaya, Ariani Indrawati, et al.
Current Drug Targets (2024) Vol. 25, Iss. 6, pp. 404-415
Closed Access
Creation and characterization of novel rat model for recessive dystrophic epidermolysis bullosa: Frameshift mutation of the Col7a1 gene leads to severe blistered phenotype
W. H. Stone, Chloe Strege, William Miller, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0302991-e0302991
Open Access
Systematic review on antipruritic therapies for patients with Epidermolysis bullosa
Tobias Welponer, Christian Puttinger, Eva W H Korte, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access
Plasma metabolomic profiling reflects the malnourished and chronic inflammatory state in recessive dystrophic epidermolysis bullosa
Yafen Chen, Hsin-Chin Lu, Ping‐Chen Hou, et al.
Journal of Dermatological Science (2022) Vol. 107, Iss. 2, pp. 82-88
Closed Access | Times Cited: 2
Learning from itch – epidermolysis bullosa is a genetically determined barrier disruption and a chronic inflammatory disease
Z Ruszczak, Shaden Abdelhadi
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 36, Iss. 1, pp. 13-16
Open Access | Times Cited: 2
Inborn errors of immunity and immunodeficiencies: Antibody‐mediated pathology and autoimmunity as a consequence of impaired immune reactions
Susana Minguet, Alexander Nyström, Dimitra Kiritsi, et al.
European Journal of Immunology (2022) Vol. 52, Iss. 9, pp. 1396-1405
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top